This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2019.
Company Filing History:
1 out of 159 
1 out of 100 Years Active: 2019
Title: Haoying Zhang: Innovator in Bone Metabolism Treatment
Introduction
Haoying Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical science, particularly in the treatment of bone metabolism-related diseases.
Latest Patents
Haoying Zhang holds a patent for an "Anti-sclerostin antibody, antigen binding fragment and medical use thereof." This patent describes a humanized antibody and chimeric antibody that specifically binds to human sclerostin. The antibodies developed by Zhang can be utilized for treating conditions such as osteoporosis, which is a critical concern in bone health.
Career Highlights
Throughout his career, Haoying Zhang has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to advancements in medical treatments.
Collaborations
Haoying Zhang has collaborated with several professionals in his field, including Jiajian Liu and Yayuan Fu. These collaborations have likely enhanced his research and development efforts.
Conclusion
Haoying Zhang is a distinguished inventor whose work in developing antibodies for bone metabolism treatment showcases his commitment to advancing medical science. His contributions are vital for addressing significant health issues such as osteoporosis.